Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company with programs in gastroenterology, oncology and virology focused on innovative therapeutics for patients with debilitating conditions and life-threatening diseases.
| EPIC: | PGNX |
| Market: | NASDAQ:PGNX |
| 52-week High/Low: | $9.41 / $3.63 |
| Sector: | Pharmaceuticals |
| Market Cap: | $386.36 m |
| Website: | www.progenics.com |
col 3
col 4
col 5
col 6
Progenics Pharmaceuticals Timeline
Article
September 13 2018
